Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Squamous Cell of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02437916
What this trial is testing

Safety Study of AMG 228 to Treat Solid Tumors

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsCancer+8 more
Amgen 30
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)Looking for participantsNCT06087614
What this trial is testing

Dose Escalation Using Hypoxia-adjusted Radiotherapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Rajiv Gandhi Cancer Institute & Research Center, India 124
Testing effectiveness (Phase 2)Ended earlyNCT02345330
What this trial is testing

Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
OncoSec Medical Incorporated 4
Testing effectiveness (Phase 2)Study completedNCT01941992
What this trial is testing

Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients

Who this might be right for
Head-and-neck Squamous Cell CarcinomaOral Mucositis
Istituto Oncologico Veneto IRCCS 120
Early research (Phase 1)Active Not RecruitingNCT05540899
What this trial is testing

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of the Larynx+2 more
American College of Radiology 14
Testing effectiveness (Phase 2)WithdrawnNCT00233636
What this trial is testing

Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerCarcinoma, Squamous Cell
AstraZeneca 28
Large-scale testing (Phase 3)Study completedNCT00003809
What this trial is testing

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Ended earlyNCT00113399
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 15
Testing effectiveness (Phase 2)Study completedNCT01283334
What this trial is testing

Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsCancer of the Head and Neck
Emory University 20
Early research (Phase 1)Study completedNCT04830592
What this trial is testing

NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Akamis Bio 36
Not applicableLooking for participantsNCT06336941
What this trial is testing

"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)

Who this might be right for
Oral Squamous Cell Carcinoma
University of Pisa 400
Testing effectiveness (Phase 2)Study completedNCT00063895
What this trial is testing

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00095901
What this trial is testing

Capecitabine For Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT06247956
What this trial is testing

Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer

Who this might be right for
Advanced Gastric Adenocarcinoma and Esophageal Squamous Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 153
Early research (Phase 1)Study completedNCT01334177
What this trial is testing

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+38 more
University of Washington 13
Testing effectiveness (Phase 2)Study completedNCT00409565
What this trial is testing

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT01316757
What this trial is testing

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+20 more
Fox Chase Cancer Center 24
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Large-scale testing (Phase 3)Study completedNCT00424255
What this trial is testing

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 688
Next Page